Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized study of fibrinolysis vs primary angioplasty in elderly patients with acute myocardial infarction
2004-001943-31Phase 4Active
- Sponsor
- Sociedad Española de Cardiología
- Start
- Nov 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of tenecteplase in myocardial infarction (MI) (2 arms), sponsored by Sociedad Española de Cardiología. Primary endpoints: Composite of all-cause death, reinfarction, or disabling stroke at 30 days and All-cause mortality at 30 days. Started Nov 2004; status: active.
02
Drugs
tenecteplase
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2004-001943-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001943-31.